Search

Prevalence of diabetes in the elderly increases, and half of the French diabetics are over the age of 75 years. The GERODIAB study is the first French multicentre, prospective, observational study designed to analyse over 5 years the influence of glycaemic control on morbidity-mortality in type 2 diabetics patients 70 years old and over. This study analysed the diabetic and geriatric factors associated with the treatment modalities, particularly insulin, at inclusion in the cohort. The cohort of 987 type 2 diabetics was divided into three groups according to the method of treatment. Slightly fewer than one-third of these patients (26.4%) were treated with insulin alone, 31% received insulin and oral antidiabetic drugs, and 42.7% oral antidiabetic drugs alone. The patients that received insulin alone were significantly older, had poorer glycaemic control ( Hb A1c = 7.9 ± 1.4, 7.8 ± 1.0 and 7.1 ± 1.2%, respectively; P < 0.001) and had greater alterations of glomerular filtration rate ( GFR). Hb A1c was below 6.5% in 15% of patients and 37.3% of patients had a GFR below 60 mL/min. The patients treated with insulin alone had significantly more hypoglycaemic episodes (respectively 53.3, 36.3 and 19.5%, P < 0.001), retinopathy, cardiovascular involvement and more specific geriatric complications, such as cognitive disorders (respectively 34.1, 31.4 and 23.6%, P = 0.006). In this specific population of elderly type 2 diabetic patients, diabetic and geriatric conditions significantly differed between the types of drug treatments. Considering low values of Hb A1c and GFR, some patients seemed overtreated and other patients received inappropriate drugs. [ABSTRACT FROM AUTHOR]

Although Alzheimer's disease (AD) is basically considered to be a neurodegenerative disorder, cerebrovascular disease is also involved. The role of vascular risk factors and vascular disease in the progression of AD remains incompletely understood. With the development of brain MRI, it is now possible to detect small-vessel disease, whose prevalence and severity increase with age. The first types of small-vessel disease to be described were white matter hyperintensities (WMHs). More recently, small areas of signal loss on T2*-weighted images, also called microbleeds (MBs), have been reported. Cerebral MBs are focal deposits of hemosiderin that indicate prior microhemorrhages around small vessels, related to either ruptured atherosclerotic microvessels or amyloid angiopathy. Consequently, using brain MRI for the detection of microangiopathy may prove useful to improve our understanding of the impact of the vascular burden in AD pathology. The relationship between microangiopathy and the clinical course of AD or the conversion of mild cognitive impairment to AD remains questionable in terms of cognitive or affective symptoms, particularly if we consider MBs. Copyright © 2012 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]

Although Alzheimer's disease (AD) is basically considered to be a neurodegenerative disorder, cerebrovascular disease is also involved. The role of vascular risk factors and vascular disease in the progression of AD remains incompletely understood. With the development of brain MRI, it is now possible to detect small-vessel disease, whose prevalence and severity increase with age. The first types of small-vessel disease to be described were white matter hyperintensities (WMHs). More recently, small areas of signal loss on T2*-weighted images, also called microbleeds (MBs), have been reported. Cerebral MBs are focal deposits of hemosiderin that indicate prior microhemorrhages around small vessels, related to either ruptured atherosclerotic microvessels or amyloid angiopathy. Consequently, using brain MRI for the detection of microangiopathy may prove useful to improve our understanding of the impact of the vascular burden in AD pathology. The relationship between microangiopathy and the clinical course of AD or the conversion of mild cognitive impairment to AD remains questionable in terms of cognitive or affective symptoms, particularly if we consider MBs. Copyright © 2012 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]

Background: There is abundant literature on the determinants of caregiver burden in Alzheimer's disease (AD), but little is known about the possible implication of specific patterns of a caregiver's attitudes towards the disease that could increase their risk of--or protect them from--emotional distress and burden. The aim of this study was to test the hypothesis that negative attitudes towards AD are associated with an increased level of burden experienced by caregivers of AD patients.Methods: Family caregivers of 51 patients with AD were asked to complete a questionnaire regarding their attitudes towards AD. In addition, we assessed the level of their quality of life, anxiety and depression as well as their perceived level of burden. In parallel, we documented the patients' characteristics: global cognitive efficiency (Mini-Mental State Examination), behavioral and affective symptoms (Neuropsychiatric Inventory) and functional level (Instrumental Activities of Daily Living).Results: The score of caregiver burden was positively correlated with negative attitudes such as authoritarianism (r = 0.41, p < 0.01) and social restrictiveness (r = 0.49, p < 0.001) as well as emotional reactions of anxiety (r = 0.44, p < 0.01) and aggressiveness (r = 0.47, p < 0.001). In addition, scores of social restrictiveness, rejection and anxiety were significantly higher in women than in men.Conclusion: These results may have implications in terms of the prevention of caregiver burden. In particular, educational and support programs for caregivers should not be limited to developing their knowledge and skills but should also target attitudes towards the disease. [ABSTRACT FROM AUTHOR]

Objective: Aging is associated with cognitive changing. Central auditory processing dysfunction may explain some understanding difficulties in elderly. It may be evaluated with the dichotic listening (DL) test, a widely-used experimental paradigm for studying inter-hemispheric interactions and attentional processes. This study examines central auditory language processing with a dichotic listening task in right-handed old subjects according to their age. Design: Cross sectional-study. Setting: memory clinic and geriatric unit. Participants: Adult group (Ad) consisted in 26 subjects (21 women and 5 men) aged 50-69 years and an old adults group (Old-Ad) consisted in 20 subjects (19 women and 1 man) aged 70 to 89 years. Measurements: DL consisted in a free-recall word task and a digit forced-attention task (forced-right: FR and forced-left: FL) in order to study central auditory language processing. In addition, we used neuropsychological tests to study executive functions and cognitive control, sustained by the prefrontal cortex. Results: In the free recall condition, we confirmed the classic right ear advantage (REA) in both groups, particularly in older subjects. In the forced condition, we observed an ear advantage with a change in ear asymmetry as a consequence of instruction: REA in FR and a left-ear advantage (LEA) in FL. We compared contaminations by the contra-lateral inattentive ear: reports of the left ear (LE) in the FR condition and reports of the right ear (RE) in the FL condition. Contaminations by the RE in the FL condition were more pronounced in Old-Ad suggesting difficulties in competition between the natural tendency for the RE and the instruction. In the Old-Ad group, the correlation between the RE score in FL and TMT B-A/A suggests an impairment in mental flexibility. Conclusion: DL may be helpful to study central auditory dysfunction in aging. Our results suggest difficulties in attentional control and executive functions. Central auditory dysfunction should be evaluated in elderly because it potentially contributes to difficulty of hearing in noisy environment with consequences in the rehabilitation of presbyacousic subjects. More studies are needed to investigate the predictive value of DL as a marker of cognitive decline, particularly executive functions. [ABSTRACT FROM AUTHOR]

Older people with diabetes represent a major and increasing proportion of our elderly population and their care requires better organisation. Targets for risk factor control and pathways of care must be adjusted to the subject's general health status. It is thus advisable to screen for frailty. We have carried out a detailed literature review of the studies published on diabetes in older people since 1990. Studies were considered if they included groups or subgroups of diabetic patients >65 years old. This review discusses the elaboration of general targets for care, the approach to risk factor control, the screening and the specific prevention or management of complications, the integration of geriatric concepts in diabetes care and the specificity of education with respect to frailty status. [ABSTRACT FROM AUTHOR]

Copyright of Les Cahiers de l'Année Gérontologique is the property of Lavoisier and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: Pressure ulcers affect predominantly the elderly and nutritional status is a known risk factor. Guidelines on pressure ulcers provide recommendation on nutritional management. Ornithine alpha-ketoglutarate (OKG) is an adjuvant treatment in undernourished elderly patients or in patients with hypercatabolism states. It is a precursor of different amino-acids which play a role in the process of healing. The objective of the study is to determine the efficacy of OKG on pressure ulcer area reduction after six weeks of treatment. Design: Multi-centre. international, randomized, comparative, double blind, parallel groups, placebo controlled study. Participants: 160 patients (ITT population) aged over 60 years with a heel pressure ulcer at stage II or III. Intervention: Patients received OKG (n=85) or placebo (n=75) once a day for 6 weeks. Measurements: Ulcer area was measured each week. using a tracer. The primary endpoint was the percentage reduction of the surface at the final visit: [(Wound areatn -- Wound areat0)/ (Wound areat0)l. Results: At inclusion, ulcer area distribution deviated from normal distribution (median ulcer area OKG 6.6cm², placebo 3.9 cm². p=0.044. Mann-Whitney test). As healing is strongly related to baseline ulcer area, the abnormal distribution was a major bias. Therefore it was decided to perform the analysis on 2 sub-groups of patients according to the mean ulcer area, i.e. above or below 8cm². The mean wound area reduction for baseline area ≤ 8 cm² are -59.5 ± 71.4% and -54.0 ± 69.0% for the OKG group and placebo groups respectively (p=0.477, Mann-Whitney test). In the group with baseline pressure ulcer area > 8 cm² no between group differences on either parameter was detected. When closure rate is considered, a significant difference in favor of OKG group is observed (- 0.07 cm²/day in the OKG group and - 0.04 cm²/day in the placebo groups respectively p=0.007, Mann-Whitney test). Thirty serious adverse events were reported in 28 patients (15 allocated to OKG and 13 to placebo). None of them was considered treatment related. Conclusion: This clinical trial supports a potential benefit of OKG 10g daily in the subgroup of patients with pressure ulcers ≤ 8 cm² surface area in elderly population when associated with debridement together with wound management according to pressure ulcer guidelines. However this study highlights methodological difficulties to perform clinical trials in old-old patients that may affect the robustness of the results for this type of study. [ABSTRACT FROM AUTHOR]

Epilepsy is a frequent condition in the elderly; however, it remains a relatively understudied condition in older adults with dementia. The diagnosis of a seizure is particularly difficult and is most often based on questions to the caregiver. Epilepsy in dementia has significant consequences on the prognosis of the underlying dementia: it can result in a worsening of cognitive performance, particularly in language, as well as a reduction in autonomy, a greater risk of injury and a higher mortality rate. In this review, management strategies are recommended for the clinician. The presence of pre-existing Alzheimer’s disease does not exempt the clinician from ruling out other symptomatic causes of seizures. Anti-epileptic drugs (AED) should be started only after the diagnosis has been clearly established, when the risk of recurrence is high, and with monotherapy whenever possible. Although few data are available, the more recent AED offer significant advantages over the older medications in this context. Copyright © 2008 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]

Weight loss, together with psychological and behavioural symptoms and problems of mobility, is one of the principal manifestations of Alzheimer's disease (AD). Weight loss may be associated with protein and energy malnutrition leading to severe complications (alteration of the immune system, muscular atrophy, loss of independence). Various explanations have been proposed such as atrophy of the mesial temporal cortex, biological disturbances, or feeding behaviours; however, none has been proven. Prevention of weight loss in AD is a major issue. It requires regular follow-up and must be an integral part of the care plan. The aim of this article is to review the present state of scientific knowledge on weight loss associated with AD. We will consider four points: the natural history of weight loss, its known etiological factors, its consequences and the various management options. [ABSTRACT FROM AUTHOR]

Transdermal nitroglycerin is commonly used and may induce contact dermatitis. The frequency of adverse skin reactions is controversial and may vary from 10% to 75%, according to various authors 33 patients using transdermal nitroglycerin for more than 7 days were examined and patch tested (nitroglycerin 0.5% aq., 2% pet, and TTS in toto) , 5 patients (15%) had adverse reactions. The patch tests were all negative in the 33 patients. Contact dermatitis occurs in many cases, about 15% of the cases with the newly available TTS, and even if patients respect the conditions for using TTS. There contact dermatitis are mainly irritant reactions and do not require transdermal nitroglycerin treatment to be stopped Nevertheless, since some cases of allergic contact dermatitis have been reported a contact dermatitis from transdermal nitroglycerin should lead to patch testing. [ABSTRACT FROM AUTHOR]

Background: Hypodermoclysis, i.e., infusion of solutions into the subcutaneous tissues, is an alternative method for hydration. The aim of our study was to describe the metabolic changes induced by hypodermoclysis of a glucose-saline solution in elderly patients.Methods: Twelve experiments were conducted in a random cross-over study, intravenous infusion (IV) vs subcutaneous infusion (SC), in 6 hospitalized patients (81.5 +/- 9.8 years). The solution (1000 mL of 5% glucose solution containing 4 g NaCl) was infused over 6 hours in fasted patients who remained in bed. Blood was sampled at -10, 0, 30, 60, 90, 120, 180, 240, 300, and 360 minutes for measurement of plasma concentrations of glucose, insulin, free fatty acids, and beta-hydroxybutyrate. Plasma concentration of cortisol was analyzed only at T-10, T0, T180, and T360.Results: The increases in glucose and insulin and the decrease in plasma concentrations of free fatty acids were lower with SC infusion than with IV infusion. The decrease in beta-hydroxybutyrate plasma concentration was lower at T300 with SC infusion than with IV infusion. The decrease in cortisol did not differ with the route. Plasma concentrations of all compounds were similar at T360.Conclusion: We conclude that hypodermoclysis of glucose-saline solution induced similar but smaller metabolic and hormonal changes than the IV infusion. [ABSTRACT FROM AUTHOR]

A diagnosis of Alzheimer's disease (AD) is associated with an increased risk of unprovoked seizures. In this observational study, we analyzed first seizures in a sample of elderly subjects with AD hospitalized in an acute geriatric care unit. Only 2.5% of the hospitalized AD patients were admitted for a first seizure. The seizures are not necessarily symptomatic of AD. Symptomatic cause must be ruled out in order to classify the syndrome before introducing antiepileptic drugs (AEDs). In practice, only recurrent unprovoked seizures or symptomatic location- related epilepsy with a high risk of recurrence should be treated with AEDs. [ABSTRACT FROM AUTHOR]

A letter to the editor is presented in response to the article "The outcome of prolonged mechanical ventilation in elderly patients: are the efforts worthwhile?" published in a 1996 issue.